Liver and Metabolic Health

Fatty Liver and MASLD, Tests, Food, Activity and Follow-Up

Understand what a fatty-liver finding can mean, why scarring is assessed separately, and how to organise a practical follow-up plan.

By Global Medicines ExportUpdated: Educational article

Test and terminology reference

What different liver findings describe

This table helps organise questions. A scan or blood result needs clinical interpretation and cannot be used alone to assign every disease stage.

Separate fat, inflammation and scarring

Term or testWhat it concernsUseful question
SteatosisFat in liver tissueWhat could be contributing in my case?
MASLDSteatosis with cardiometabolic risk criteriaWhich risk factors and other causes were assessed?
MASHSteatohepatitis in the metabolic disease contextIs inflammation suspected, and what evidence is needed?
FibrosisScarringHow was my risk assessed?
Liver enzymesBlood markers of liver injuryWhat does the trend mean with my other results?
ElastographyA measure of liver stiffnessIs further assessment needed to interpret this result?

What do fatty liver, MASLD and MASH mean?

Fatty liver describes fat accumulation in the liver. Current terminology uses steatotic liver disease as a wider category. MASLD means metabolic dysfunction-associated steatotic liver disease and involves liver fat with cardiometabolic risk criteria. MASH describes metabolic dysfunction-associated steatohepatitis, where inflammation is part of the condition.

Older reports may say NAFLD or NASH. Bring those reports to the clinician rather than assuming a new name means a new diagnosis. The team can explain how the previous findings fit current terminology and whether the assessment needs updating.

Why does the clinician ask about more than body weight?

Type 2 diabetes, blood pressure, cholesterol and other metabolic factors can be relevant. The team also asks about alcohol, medicines and other liver conditions. Several causes can coexist, and an honest description helps the clinician select the right investigations and advice.

Describe the amount and pattern of alcohol use, including changes over time, and bring every supplement or herbal product. If reducing alcohol is difficult, ask for support. Someone who may be alcohol-dependent needs medical guidance about stopping safely.

What can blood tests and ultrasound tell you?

A blood panel and ultrasound can help identify a reason for further assessment, but they answer different questions. Ultrasound may show liver fat. Liver enzymes give information about injury and need interpretation with the history and other results. The clinician may also test for other causes of liver disease.

Ask what is established, what is suspected and what remains to be checked. Keep copies with dates. If a report says fatty liver without explaining scarring risk, ask whether further assessment is appropriate in your circumstances.

Why might you need a fibrosis assessment?

Scarring affects longer-term care, so clinicians may use blood-based assessment and, when appropriate, an elastography scan that measures liver stiffness. A stiffness result needs interpretation alongside the rest of the assessment. It is useful to ask what the test can and cannot establish in your case.

Some people need specialist review or further testing. A biopsy is considered selectively rather than being required for everyone with liver fat. Ask who will interpret the next test, how you will receive the result and what findings would change follow-up.

What food changes can you start discussing?

Describe a usual week, including drinks, snacks and meals outside the home. A practical plan can address sugary drinks, portion sizes and the balance of vegetables, whole grains, protein and fats. Choose changes that fit your budget and other health needs, with dietitian support when available.

If weight loss is appropriate, gradual sustained change is preferred to a crash diet. NIDDK notes that rapid weight loss and malnutrition can worsen liver disease. The weight-loss plateau guide can help you prepare questions when progress slows or reduced appetite makes it hard to eat adequately.

Can activity help when the scale barely changes?

Physical activity can benefit liver and metabolic health even when weight loss is limited. Choose a level that fits your current ability and build gradually. Walking, an adapted indoor activity and strength work can each form part of a sustainable routine.

If joint problems, balance, breathlessness or another condition limits you, discuss an adapted plan. The guide to strength training during weight loss explains how a functional goal can be tracked. Record what you can repeat comfortably rather than using the scale as the only measure of progress.

What about liver supplements and prescription treatment?

Give the clinician the labels for products promoted as liver cleanses or detoxes. Some supplements and herbal preparations can injure the liver, and a marketing claim does not establish a benefit for MASLD. Ask what evidence exists for the actual ingredient and whether it can interact with your medicines.

Prescription options depend on the disease findings, other conditions and local approvals. Current AASLD guidance includes treatments for selected MASH populations, so advice about eligibility must use an up-to-date specialist assessment. Continue management of diabetes, cholesterol and blood pressure with the responsible teams.

What should an ongoing care plan include?

Ask which tests will be followed and when, whether a liver specialist is involved and which changes in symptoms need earlier contact. Keep a list of metabolic health goals and appointments so care does not focus solely on one liver-enzyme result.

Call emergency services for vomiting blood, black tarry stools or sudden marked confusion, particularly with known liver disease. New yellowing of the eyes or skin, increasing abdominal swelling or worsening general health needs prompt medical advice. Tell the team about known liver findings and current medicines.

Export product support

Need product, pack, and documentation details?

Global Medicines Export can support international B2B enquiries for product availability, strengths, pack information, quotation coordination, and shipment documentation review.

Common questions

Can fatty liver be present without symptoms?

Yes. It is often found during tests for another reason. Follow-up is based on the findings and risk assessment rather than symptoms alone.

Does an ultrasound showing fat tell me how much scarring I have?

Fat and fibrosis are different findings. Ask whether a separate scarring-risk assessment or another test is needed.

Does MASH mean the same thing as simple steatosis?

MASH describes steatohepatitis, which includes inflammation in the metabolic disease context. The clinician can explain what evidence supports that diagnosis.

Can I have MASLD at a weight I consider normal?

Assessment considers cardiometabolic factors and other causes as well as body weight. Discuss your individual findings with the clinician.

Will everyone need a liver biopsy?

No. Clinicians select tests according to the likely cause and risk. Ask what information a proposed test would add.

Should I stop my cholesterol or diabetes medicine because a scan shows liver fat?

Ask the prescribing team to review the actual medicine and findings. Do not infer a treatment change from the scan wording alone.

What should I bring to a follow-up?

Bring dated tests and scans, your medicine and supplement labels, alcohol history and a short record of the food and activity changes you have tried.

Important medical note

This article is for general educational information only. It is not medical advice, diagnosis, or a treatment plan. Medicines should be used only under the guidance of a qualified healthcare professional. Product availability, export documentation, and quotation support do not imply that a medicine is appropriate for any individual patient.

References